After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q3 2018 call → NOThe question asks whether management reports that the most important positive developments of the period happened so late in the reported period, or shortly after it ended, that the results being presented contain little or none of their effect — with management itself marking the timing. Let me review the transcript for any such late-breaking positive events. Key events discussed: - VIVITROL sales growth - ARISTADA sales growth, ARISTADA INITIO launch - AMPYRA revenues higher than expected due to delayed generic entry - ALKS 5461 PDUFA date January 31, AdCom November 1 - ALKS 3831 ENLIGHTEN-2 topline results later in Q4 - BIIB098 NDA submission by year-end - ALKS 4230 clinical progress Now, are there any positive developments that happened late in the period or after period-end that management says the results don't reflect? Looking at the transcript: - ARISTADA INITIO launch: "The quarter was highlighted by the launch of our new initiation product ARISTADA INITIO." This was launched in Q2 (mentioned in Q2 call), and in Q3 they saw acceleration. But this is not described as happening late in Q3 or after. - AMPYRA: "stronger-than-expected as generic entrants were delayed coming to market" - this is a positive but it's about delayed competition, not a late-breaking event. - ALKS 3831: "we're on track for topline results later in the fourth quarter" - this is future, not yet happened. - ALKS 5461: AdCom November 1 - future. The question asks about positive developments that happened so late in the period or shortly after it ended that results contain little or none of their effect. Looking at the transcript, I don't see management describing any specific concrete positive development that occurred at the very end of the quarter or after quarter-end that the results don't reflect. The AMPYRA upside is described as "stronger-than-expected" due to delayed generics, but this is spread across the quarter, not a late event. The ARISTADA INITIO launch was in Q2, and Q3 results include its effect. The ALKS 3831 topline results are expected "later in the fourth quarter" - future, not yet happened. The BIIB098 NDA submission is "by year-end" - future. The 4230 subcutaneous study - "expect to initiate that study early next year" - future.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...